Refine by
Detection Of Biomarkers Articles & Analysis
32 news found
Ward Detwiler, our President & CEO, had the opportunity to speak about how STAGE is innovating the world of MR at MedTech Strategist Innovation 2021. ...
This study focused on the performance of Seravue and the LC-SPIK biomarker in detecting hepatocellular carcinoma (HCC) in a pool of nonalcoholic fatty liver disease (NAFLD) related cirrhosis patients. Here, LC-SPIK had an AUC of 0.841 and significantly outperformed AFP, the most common biomarker used for HCC detection today. ...
The study found that sex differences can be observed via digital biomarkers, which has the potential to impact diagnosis and treatment of AD. “Our research shows how digital biomarkers can detect sex-based differences which are often overlooked when using standardized cognitive neuropsychological assessment,” said Antonella ...
The study found that sex differences can be observed via digital biomarkers, which has the potential to impact diagnosis and treatment of AD. “Our research shows how digital biomarkers can detect sex-based differences which are often overlooked when using standardized cognitive neuropsychological assessment,” said Antonella ...
” Highlights from the first quarter and recent weeks include: The American College of Gastroenterology (“ACG”) updated its clinical guideline for the diagnosis and management of esophageal precancer, endorsing, for the first time, nonendoscopic biomarker screening to detect precancer and prevent highly lethal esophageal cancer, providing ...
Biomarker detection can provide insight into the mechanism of action or resistance of new drugs in disease models. Creative Proteomics can provide detection services for cytokines and biomarkers for the majority of pharmaceutical R&D personnel. Its Cytokine division has complete infrastructure and advanced equipment, and ...
Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer’s Drug Discovery Foundation (ADDF). ...
CAC is a recognized vital biomarker for detection of cardiovascular disease. Nanox.AI believes that early detection and subsequent treatment of cardiovascular disease has the potential to significantly decrease the morbidity and mortality of this highly prevalent condition. ...
Today, Novosanis has launched its novel solution for oncology research applications. Together with our sister company DNA Genotek, we have developed a novel stabilization chemistry, UAS, for the preservation of extracellular vesicle (EV) RNA, and cell-free DNA (cfDNA) in urine, collected with Colli-Pee. Novosanis hereby offers a solution for applications in the field of oncology research and ...
We are pleased to announce that Dr Barbara Guinn from University of Hull UK is the winner of the EACR & Novosanis Grant for Cancer Biomarker Detection in Urine. The grant awards the most impactful proposal in cancer related research using urine as a sample type, which has shown to be an emerging non-invasive liquid biopsy. ...
According to X-ZELL’s Head of Engineering & Product Development, Sven Strache, the technology is crucial to the routine discovery of next-generation biomarkers for early cancer detection and has set a new standard for white blood cell depletion from whole blood. ...
“In 2017 we developed a platform technology capable of detecting previously undetectable cells in a routine lab,” Dr Bhakdi commented. ...
Novosanis is offering a research grant exclusive to EACR members to stimulate innovative research in cancer biomarker detection using urine as a sample type. As urine sampling is easy, quick and non-invasive it has the potential to change the way cancer is detected and monitored today. ...
The results showed that all three different first-void urine collection volumes with Urine Conservation Medium (UCM) allow for biomarker detection. Human Papillomavirus (HPV) can be detected in first-void urine Methods to optimize first-void urine collection Study summary: Impact of different urine volumes on detection of ...
Methylation patterns on the promoter regions of tumor suppressor genes involved in cervical cancer development have demonstrated to be sensitive biomarkers to detect cervical cancer and severe precursor stadia (CIN3+). ...
Analysis of other potential blood-based biomarkers using CAMP study samples is ongoing. Validation of additional metabotypes of ASD is expected to result in the ability to detect a still higher percentage of children at risk of ASD using this approach. ...
The Oncomine Precision Assay, which is designed to detect key biomarkers from formalin-fixed paraffin-embedded (FFPE) tissue and liquid biopsy specimens, contains more than 50 cancer-related biomarkers and has the lowest sample input requirements on the market for detection of both DNA and RNA variants. ...
Co-founders and biomedical engineers Corey Centen and Sarah Smith founded Bodyport to develop a novel biomarker platform that could detect early signs of cardiovascular disease, incorporating proprietary sensor technology into a bathroom scale form factor. Rather than relying on wearables, the Bodyport Scale is designed to detect cardiac signals ...
Under the terms of the agreement, the companies will collaboratively validate the biomarkers for a test that will be based on Thermo Fisher's Oncomine Precision Assay and used to identify variant-positive patients. ...
There is a high probability that this disease can be detected in the exhaled breath but also monitoring the impact of treatment or medication in exhaled breath is highly relevant. ...